View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
November 13, 2005

Sun Microsystems’ technology to combat counterfeit drugs

Sun Microsystems has launched its Sun RFID industry solution for drug authentication, a combination of software, hardware and services that is intended to combat pharmaceutical drug counterfeiting.

By CBR Staff Writer

The Sun system is designed to stem drug counterfeiting by verifying and certifying the authenticity of drugs using electronic product codes.

Drug counterfeiting and diverting (fraudulently obtaining prescription drugs and reselling them) introduce inefficiencies into the supply chain, dilute company brand names, represent enormous costs to pharmaceutical manufacturers, and expose consumers to health risks via counterfeit dispensing.

Unlike packaged goods, pharmaceutical drugs have high market values, unique storage requirements and small unit sizes that make it necessary to track individual bottles or even individual doses.

Sun is leveraging our RFID-technology expertise, along with that of third-party companies, to bring drug manufacturers and distributors a solution that helps distinguish legitimate products from counterfeit and helps our customers prevent loss in revenue and maintain drug integrity, said Vivek Khandelwal, principal RFID solutions manager for Sun’s RFID Business Unit.

Content from our partners
Rethinking cloud: challenging assumptions, learning lessons
DTX Manchester welcomes leading tech talent from across the region and beyond
The hidden complexities of deploying AI in your business

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
THANK YOU